Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hemorrhage/Bleeding	Blood and lymphatic system disorders	Dasatinib 100 mg	1	3	1
other	Hemorrhage/Bleeding	Blood and lymphatic system disorders	Dasatinib 70 mg	0	4	0
other	Hyperglycemia	Metabolism and nutrition disorders	Dasatinib 100 mg	1	3	1
other	Hyperglycemia	Metabolism and nutrition disorders	Dasatinib 70 mg	0	4	0
other	Thrombosis/thrombus/embolism	Vascular disorders	Dasatinib 100 mg	1	3	1
other	Thrombosis/thrombus/embolism	Vascular disorders	Dasatinib 70 mg	0	4	0
other	Vascular- other	Vascular disorders	Dasatinib 100 mg	1	3	1
other	Vascular- other	Vascular disorders	Dasatinib 70 mg	0	4	0
other	Pneumonia	Infections and infestations	Dasatinib 100 mg	0	3	0
other	Pneumonia	Infections and infestations	Dasatinib 70 mg	1	4	1
other	Urinary tract infection	Infections and infestations	Dasatinib 100 mg	0	3	0
other	Urinary tract infection	Infections and infestations	Dasatinib 70 mg	1	4	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00563290/events